What Happens If You Mix Cosentyx with the MMR Vaccine?
Cosentyx (secukinumab), a biologic IL-17 inhibitor for psoriasis, psoriatic arthritis, and ankylosing spondylitis, suppresses parts of the immune system. The MMR vaccine (measles, mumps, rubella) is a live attenuated vaccine that requires a functional immune response to work. Mixing them—whether by administering concurrently or too closely—risks reducing vaccine effectiveness and increasing infection chances from the live virus [1][2].
Guidelines from the CDC and Cosentyx prescribing information advise avoiding live vaccines during treatment and for varying periods after. No direct studies test "mixing" (e.g., in one syringe), but general rules apply to co-administration [3].
Recommended Timing Between Cosentyx and MMR
- Before starting Cosentyx: Complete MMR at least 4 weeks prior. This ensures immunity develops fully [1][4].
- During Cosentyx treatment: Do not give live vaccines like MMR. The drug impairs immune response, so vaccination may fail and could cause disseminated infection [2][3].
- After stopping Cosentyx: Wait 4-6 months before MMR, based on drug clearance (half-life ~27-30 days). Revaccination may be needed post-treatment [1][4].
Swiss product info specifies no live vaccines for 2 years after the last dose in some cases, but U.S. labels use shorter windows [5].
Why Live Vaccines Like MMR Pose a Specific Risk
Cosentyx selectively blocks IL-17, aiding fungal/bacterial defense but not fully neutralizing viral threats from live vaccines. Case reports with similar biologics (e.g., TNF inhibitors) show vaccine failure rates up to 50% and rare disseminated varicella [2]. No Cosentyx-MMR cases reported, but risk mirrors other immunosuppressants [3][6].
What About Inactivated Vaccines?
Safe to give with Cosentyx—no live virus risk. Examples: flu shot, COVID-19, Tdap, pneumococcal. Studies confirm adequate response, though slightly reduced titers possible [1][4].
Real-World Patient Concerns and Reports
Patients on forums like Reddit and Drugs.com report doctors delaying MMR boosters until off Cosentyx. No confirmed adverse events from accidental co-administration, but immunogenicity drops noted in psoriasis trials (e.g., lower pneumococcal response) [6]. Consult a doctor for titers to check immunity.
Alternatives for Immunity on Cosentyx
Test antibody levels pre-treatment. If non-immune, prioritize inactivated options or delay biologics. Post-treatment revaccination restores response in most [4].
Sources
[1] Cosentyx Prescribing Information (Novartis)
[2] CDC: Use of Immunosuppressants and Immunizations
[3] DrugPatentWatch.com - Cosentyx Patent Status (for drug details)
[4] ACR Guidelines on Vaccinations in Rheumatic Diseases
[5] Swissmedic Cosentyx Summary
[6] PubMed: Vaccine Response in IL-17 Inhibitors